SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001415889-12-001223
Filing Date
2012-08-14
Accepted
2012-08-14 08:02:20
Documents
10
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vistagen10q_june302012.htm 10-Q 773373
2 EXHIBIT 31.1 ex31-1.htm EX-31 9282
3 EXHIBIT 31.2 ex31-2.htm EX-31 11662
4 EXHIBIT 32 ex32.htm EX-32 5825
  Complete submission text file 0001415889-12-001223.txt   4612158

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vsta-20120630.xml EX-101.INS 616377
6 XBRL TAXONOMY SCHEMA DOCUMENT vsta-20120630.xsd EX-101.SCH 66828
7 XBRL TAXONOMY CALCULATION LINKBASE DOCUMENT vsta-20120630_cal.xml EX-101.CAL 51961
8 XBRL TAXONOMY DEFINITION LINKBASE DOCUMENT vsta-20120630_def.xml EX-101.DEF 105947
9 XBRL TAXONOMY LABEL LINKBASE DOCUMENT vsta-20120630_lab.xml EX-101.LAB 350102
10 XBRL TAXONOMY PRESENTATION LINKBASE DOCUMENT vsta-20120630_pre.xml EX-101.PRE 209159
Mailing Address 384 OYSTER POINT BOULEVARD, NO. 8 SOUTH SAN FRANCISCO CA 94080
Business Address 384 OYSTER POINT BOULEVARD, NO. 8 SOUTH SAN FRANCISCO CA 94080 650-244-9997 X224
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-54014 | Film No.: 121029517
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences